Kode Biotech is pleased to announce that the Kode Technology Illustrated Technical Manual eBook is now available for download from The University of Auckland research space repository. This illustrated technical manual is designed to provide scientists with technical information on… Read More »Kode Technology Illustrated Technical Manual
By Jamie Morton Original Article Kiwi-developed technology – using “synthetic paint” to coat the outside of our red blood cells – could offer a low-cost way to test for Covid-19 immunity. The test, carried out in a just-published, uses a… Read More »Covid 19 coronavirus: Kiwi tech could offer low-cost immunity test
Third place Berlin Falling Walls Lab Finale 2018 Original Article Auckland University of Technology’s Ankita Poudyal, winner of the 2018 Falling Walls Lab New Zealand, won third place in the international finale event held in Berlin on 8 November with… Read More »Filter research wows at Falling Walls
Original Article Professor Stephen Henry has been awarded the Pickering Medal by the Royal Society Te Apārangi for his development and commercialisation of a surface-modification technology, called Kode™ Technology, which shows huge promise for therapeutic use including fighting cancer, reducing… Read More »2017 Pickering Medal: Painting cells and surfaces with bio-paints for widespread beneficial use
Simon Pound | Business is Boring boss | The Spinoff article Business is Boring is a weekly podcast series presented by The Spinoff in association with Callaghan Innovation. Host Simon Pound speaks with innovators and commentators focused on the future… Read More »The cure for cancer may be closer than we think, all thanks to a Kiwi invention
Hamilton, NZ, 18 May 2017 – Twelve finalists have been selected for the fifth annual KiwiNet Research Commercialisation Awards, designed to celebrate commercialisation success within New Zealand’s universities and Crown Research Institutes. The innovative researchers and cutting edge research commercialisation… Read More »2017 finalists showcase research driving innovation
Area of focus: Our focus is to get Kode Technology licensed broadly as a core component that enables the next generation of therapeutics, diagnostics and high-value consumer products.Commencement date: February 2017Location: JLABS@TMC
Original article by Lucy Warhurst, Newshub A New Zealand-made technology behind a promising breakthrough cancer treatment is about to get a major boost. The Auckland engineering professor behind it has become the first Australasian to secure a spot in the world-leading… Read More »Kiwi-made technology could cure cancer
BioLineRx Buys U.K. Cancer Immunotherapeutics Firm Agalimmune GEN News Highlights Original Article BioLineRx has bought U.K. anticancer company Agalimmune for $6 million in a 50/50 cash and shares-based deal to acquire its immunotherapy platform and late preclinical-stage compound AGI-134. BioLineRx… Read More »BiolineRx acquires Agalimmune, a licensee using Kode Technology as an immuno-oncotherapeutic
Technology that transforms your cells | Stephen Henry | TEDxChristchurch What if you could make your cells behave however you wanted them to? What if you could help your immune system easily identify and target hard-to-detect cancers, or make molecules… Read More »CEO, Stephen Henry presents at TEDxChristchurch